CERENOVUS Neurothrombectomy Devices Registry is a study for adults who have had an acute ischemic stroke. An ischemic stroke happens when a blood clot blocks a blood vessel in the brain. The study looks at the use of special tools, called neurothrombectomy devices, to help remove these clots. The devices being studied include the EmboTrap® Revascularization Device, the CERENOVUS Large Bore Catheter, EMBOVAC™ Aspiration Catheter, and the CEREGLIDE 71 Intermediate Catheter. These tools are already on the market and the study aims to see how well they work in real life settings. Participants must be 18 or older, have signed a consent form, and be diagnosed with a stroke due to a blocked blood vessel. They should also not be part of other clinical trials that might affect the study results. The study is important for understanding how these devices help patients with strokes.

• Study focuses on adults aged 18 and older with acute ischemic stroke.
• Participants must not be in other conflicting clinical trials.
• Consent is required from the participant or their representative.